Adolescents and adults who have had gastric bypass surgery were able to maintain weight loss five years post-op, but for adolescents, the procedure more often reversed the course of diabetes and hypertension.
Patients with type 2 diabetes and kidney disease who received the SGLT2 inhibitor canagliflozin, had a lower risk of kidney failure and cardiovascular events as compared to a placebo group, a new study shows.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
